Probe-based optical fiberscopy for the direct observation of peripheral pulmonary lesions.


Journal

Respiratory investigation
ISSN: 2212-5353
Titre abrégé: Respir Investig
Pays: Netherlands
ID NLM: 101581124

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 28 02 2019
revised: 10 06 2019
accepted: 12 06 2019
pubmed: 30 7 2019
medline: 17 3 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

Peripheral pulmonary lesions are rarely observed directly before transbronchial biopsy. This study aimed to characterize the differences between malignant and benign peripheral pulmonary lesions according to the findings of direct observation using probe-based optical fiberscopy. Thirty patients who underwent probe-based optical fiberscopy in combination with bronchoscopy using endobronchial ultrasonography with a guide sheath for the evaluation of peripheral pulmonary lesions were prospectively included in this study. The patients were divided into the malignant and benign groups according to their final diagnosis. The findings of probe-based optical fiberscopy in the two groups were compared. The numbers of patients who were diagnosed using histological or bacteriological analyses via bronchoscopic sampling in the malignant and benign groups were 20/23 (87.0%) and 2/7 (28.6%), respectively. On probe-based optical fiberscopy, angiogenesis and vascular engorgement were observed only in the malignant group. The disappearance of subepithelial microvessel transparency and presence of bronchiolar stenosis were observed more frequently in the malignant group (78.3% and 60.9%) than in the benign group (28.6% and 28.6%), whereas increased mucus secretion was observed more frequently in the benign group (71.4%) than in the malignant group (8.7%). These results suggest that the findings of direct observation using probe-based optical fiberscopy are useful for differentiating malignant from benign peripheral pulmonary lesions. UMIN-CTR; UMIN000018796; URL: https://www.umin.ac.jp/ctr/index.htm.

Sections du résumé

BACKGROUND BACKGROUND
Peripheral pulmonary lesions are rarely observed directly before transbronchial biopsy. This study aimed to characterize the differences between malignant and benign peripheral pulmonary lesions according to the findings of direct observation using probe-based optical fiberscopy.
METHODS METHODS
Thirty patients who underwent probe-based optical fiberscopy in combination with bronchoscopy using endobronchial ultrasonography with a guide sheath for the evaluation of peripheral pulmonary lesions were prospectively included in this study. The patients were divided into the malignant and benign groups according to their final diagnosis. The findings of probe-based optical fiberscopy in the two groups were compared.
RESULTS RESULTS
The numbers of patients who were diagnosed using histological or bacteriological analyses via bronchoscopic sampling in the malignant and benign groups were 20/23 (87.0%) and 2/7 (28.6%), respectively. On probe-based optical fiberscopy, angiogenesis and vascular engorgement were observed only in the malignant group. The disappearance of subepithelial microvessel transparency and presence of bronchiolar stenosis were observed more frequently in the malignant group (78.3% and 60.9%) than in the benign group (28.6% and 28.6%), whereas increased mucus secretion was observed more frequently in the benign group (71.4%) than in the malignant group (8.7%).
CONCLUSIONS CONCLUSIONS
These results suggest that the findings of direct observation using probe-based optical fiberscopy are useful for differentiating malignant from benign peripheral pulmonary lesions.
TRIAL REGISTRY BACKGROUND
UMIN-CTR; UMIN000018796; URL: https://www.umin.ac.jp/ctr/index.htm.

Identifiants

pubmed: 31353288
pii: S2212-5345(19)30066-8
doi: 10.1016/j.resinv.2019.06.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-489

Informations de copyright

Copyright © 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Auteurs

Makoto Kosaka (M)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: m.kosaka@hotmail.co.jp.

Masanori Yasuo (M)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: yasumasa@shinshu-u.ac.jp.

Fumiya Kinota (F)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: kinotafumiya@gmail.com.

Ryosuke Machida (R)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: machiryo@shinshu-u.ac.jp.

Yoshiaki Kitaguchi (Y)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: kitaguti@shinshu-u.ac.jp.

Atsuhito Ushiki (A)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: atsuhito@shinshu-u.ac.jp.

Hiroshi Yamamoto (H)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: yama5252@shinshu-u.ac.jp.

Takeshi Uehara (T)

Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: tuehara@shinshu-u.ac.jp.

Kazutoshi Hamanaka (K)

The Second Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: kham@shinshu-u.ac.jp.

Satoshi Kawakami (S)

Department of Radiology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: kawasato@shinshu-u.ac.jp.

Masayuki Hanaoka (M)

The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Electronic address: masayuki@shinshu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH